BTL Vanquish


BTL Aesthetics has succeeded in creating a truly painless, effective fat reduction device. Boasting the largest treatment area in the industry, the Vanquish uses newly developed Selective RF™ energy technology to address fat reduction in non-invasive treatments. During treatment, the patient lies underneath the device’s ergonomically designed panel array (or applicator), which is positioned over the targeted area at least 1 to 2 cm from the skin, delivering RF-based energy and affecting induced apoptosis in the fat layers.

The Vanquish’s applicator-generator circuitry delivers energy selectively to tissue layers with specific impedance, focusing the RF energy into fat layers, while restricting the delivery of high heat elsewhere. A multipolar focused field shapes the electromagnetic energy field to optimize penetration and maximize the treatment area, meaning the system automatically tunes the circuitry to selectively deliver the energy with no risk of burning the skin or overheating muscles or internal organs.


Everything About it Whispers Safety:

The Vanquish utilizes real-time impedance tuning circuitry representing the breakthrough radiofrequency technology (RF). The selectively RF field is precisely focused into deep tissue layers while then skin is automatically cooled by the air. Targeted deep layers remain at higher temperatures compared with overlying skin.

Tissue Selectivity:

The groundbreaking design of energy delivery helps target the thermal effect into the deep tissue while protecting surrounding layers.

Frequencies employed are best matched with the impedance of deep tissue and specifically affect those layers.

Frequently Asked Questions:

Q: What is the Vanquish procedure?

A: The Vanquish system is a non-invasive, non-contact Selective RF Technology that selectively heats adipose tissue to the point of apoptosis, while the surrounding tissue remains unaffected. The result is a safe and natural decrease in the adipose tissue layer.

Q: How does the Vanquish procedure work?

A: The Vanquish delivers energy based on the impedance of adipose tissue. The device constantly adjusts energy delivery in order to induce and maintain homogeneous heating of the tissue. Once the adipocytes reach therapeutic temperature, the adipocytes will become apoptotic, resulting in the cell death.

Q: What happens to the fat cells?

A: The fat cells that reach and maintain therapeutic temperature will eventually die through the natural process known as apoptosis or “programmed cell death.”

Q: How hot is “hot”?

A: Fat cells have lower conductivity than the surrounding tissue such as skin and muscles.  The Vanquish is able to selectively heat the fat cells to the temperature of 44 – 45°C while the surrounding tissue remains unaffected at 40 – 41°C.

Q: Who developed the Vanquish procedure?

A: Apoptosis is the process of programmed cell changes and death that may occur in multicellular organisms. In contrast to necrosis, which is a form of traumatic cell death that results from acute cellular injury, apoptosis generally confers advantages during an organism’s life cycle. Unlike necrosis, apoptosis produces cell fragments called apoptotic bodies that phagocytic cells are able to engulf and quickly remove before the contents of the cell can spill out onto surrounding cells and cause damage. Research in and around apoptosis has increased substantially since the early 1990s. Fat cells are vulnerable to the effects of selective heating. Their initial evidence, published in Lasers in Surgery and Medicine in 2013, concluded that controlled local tissue heating can induce selective fat cell reduction and subsequent loss of subcutaneous fat without damaging other tissue layers. This led to the development of the patented selective RF technology behind the non-invasive Vanquish procedure.

Q: Who stands behind the Vanquish?

A: Established in 1993, BTL has become one of the major world manufacturers of medical devices. BTL’s primary segments include cardiology, such as holter monitoring and stress test systems, PT, pneumology, and medical aesthetics. The BTL’s aesthetic division manufactures non-surgical aesthetic devices that represent the best in body contouring, fat reduction, skin tightening and anti-wrinkle and anti-cellulite care. The BTL manufacturing and R&D facilities have been ISO 13485 and Canadian CMDCAS certified. The BTL products are CE marked and many of them have been cleared by the Health Canada, US FDA, as well as by a number of other regulatory bodies.

Q: How is the Vanquish treatment performed?

A: After the patient is positioned comfortably, the applicator is placed over the treatment area. This is a non-contact procedure, therefore, the device does not come in direct contact with the patient. Once the treatment begins the device measures the impedance of the tissue and begins to “tune” to the adipose tissue.  The treatment provider will monitor the patient response and tuning throughout the treatment. The abdomen and love handles are treated for 30 minutes.

Q: What results can my patient expect to see?

A: After a series of four 30 minute treatments, clinical studies demonstrate that the Vanquish procedure produces consistent visible and measurable results, with high patient satisfaction.

Q: How long will results last?

As long as the patient maintains their current weight and lifestyle, the results should remain for an indefinite period of time.

Q: How does the Vanquish compare with other technologies?

A: The Vanquish is the first non-contact, hands-free body contouring device on the market.  Unlike other non-invasive procedures, the Vanquish is pain free and easy to operate. There is no risk of operator fatigue and because of the ease of application, there is very little room for human error. This means consistent results. Unlike other non-invasive devices that require multiple small treatment areas and lengthy treatment sessions, the Vanquish provides the largest treatment area in the industry, all in 30 minutes.

Q: What are the common side effects after the procedure?

A: Patients are able to return immediately to their daily routine. Side effects are minimal and transient and include mild redness, warmth, and tissue tenderness.  These side effects last minutes or up to an hour post treatment.

Q: Who is a suitable candidate for treatment?

A: The Vanquish is for patients who have areas of unwanted fat. The Vanquish is not a weight reduction treatment for people who are obese, or a substitute for surgical methods such as liposuction or gastric bandage. Suitable candidates possess good overall health.